Chronix news

Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy

Chronix Biomedical

Data from pilot studies using Chronix’s CNI test submitted for presentation at a high profile scientific meeting...

Chronix Biomedical provides update on studies and presentations

Chronix Biomedical

Data from pilot studies using Chronix’s CNI test submitted for presentation at a high profile scientific meeting...

10 Cancer Symptoms

The Times

The best way to fight cancer is to diagnose it in its early stage...

WORLD CANCER DAY

The Times

World Cancer Day is a perfect opportunity to focus on your health state...

Blood test could identify aggressive prostate cancer

The Times

The Times: thousands of men with prostate cancer could be saved from unnecessary operations thanks to a blood test...

Chronix Biomedical updates on progress with prostate and pancreatic cancer validation studies

Chronix Biomedical

Chronix Biomedical, Inc., a developer of novel cancer blood-based molecular diagnostics, is pleased to update investors on the progress of two clinical studies...